|N/A|CsnPharm

CAS No.: 1196070-26-4

Synonyms: GSK2190915 sodium salt;AM-803 sodium;GSK-2190915A

GSK2190915 sodium salt is a potent FLAP(5-Lipoxygenase-activating protein) inhibitor with binding IC50 of 2.9 nM.

规格	价格	促销价格	库存	数量

400-920-2911

加入购物车大规格询价

产品咨询

400-920-2911

纯度 & 质量文件批次:

生物活性

描述GSK2190915 sodium salt is a potent FLAP(5-Lipoxygenase-activating protein) inhibitor with binding IC50 of 2.9 nM.
临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT00812929	Asthma	Phase 2	Completed	-	United States, Colorado ... more >> GSK Investigational Site Denver, Colorado, United States, 80230 United States, Massachusetts GSK Investigational Site North Dartmouth, Massachusetts, United States, 02747 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73120 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina GSK Investigational Site Orangeburg, South Carolina, United States, 29118 United States, Texas GSK Investigational Site El Paso, Texas, United States, 79925 Collapse <<
NCT00850642	-	-	Terminated	-	-
NCT00812929	-	-	Completed	-	-

实验方案

技术信息

CAS号	1196070-26-4	储存条件	粉末液体 -20°C:3-6 月 -80°C:12月
分子式	C38H42N3NaO4S	运输	蓝冰
分子量	659.81	别名	GSK2190915 sodium salt;AM-803 sodium;GSK-2190915A;Fiboflapon Sodium;AM-803;GSK-2190915;2190915

大规格询价

号为必填项

姓名: 邮箱: 手机号:

留言:

提交

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT00812929	Asthma	Phase 2	Completed	-	United States, Colorado ... more >> GSK Investigational Site Denver, Colorado, United States, 80230 United States, Massachusetts GSK Investigational Site North Dartmouth, Massachusetts, United States, 02747 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73120 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina GSK Investigational Site Orangeburg, South Carolina, United States, 29118 United States, Texas GSK Investigational Site El Paso, Texas, United States, 79925 Collapse <<
NCT00850642	-	-	Terminated	-	-
NCT00812929	-	-	Completed	-	-
NCT00850642	Asthma	Phase 2	Terminated	-	Canada, Ontario ... more >> GSK Investigational Site Hamilton, Ontario, Canada, L8N 4A6 GSK Investigational Site Kingston, Ontario, Canada, K7L 2V6 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H4J 1C5 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 United Kingdom GSK Investigational Site Glasgow, Lanarkshire, United Kingdom, G12 0YN GSK Investigational Site Leicester, Leicestershire, United Kingdom, LE3 9QP GSK Investigational Site London, United Kingdom, NW10 7EW GSK Investigational Site Manchester, United Kingdom, M23 9QZ Collapse <<

请登录您的专属账户